| Size & multiples | |||
| Market Cap | $13.45B | Enterprise Value | $15.06B |
| P/E (TTM) | 79.74× | PEG (trailing) | — |
| P/S | 0.99× | P/FCF | 32.64× |
| EV/EBITDA | 28.57× | EV/EBIT | 41.15× |
| EV/Sales | 1.10× | EV/FCF | 36.55× |
| FCF Yield | 3.06% | Buyback Yield | 0.32% |
| Owner Earnings (TTM) | $371.7M | Owner Earnings Yield | 2.76% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.77 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 12.87% |
| After-tax Cost of Debt | 4.69% | Synthetic credit rating | BB+ |
| Cost of Debt · embedded (pre-tax) | 6.17% | Cost of Debt · marginal (synthetic) | 5.38% |
| WACC | 11.59% | ROIC | 5.28% |
| EVA Spread (ROIC−WACC) | −6.31% | EVA | -$270.8M |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $0.87 · revenue TTM $13.65B · FCF TTM $412.1M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 88th · EV/EBITDA 85th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 79.7x | 24.4x | 12.9x–38.8x | 88 ↑rich |
| EV/EBITDA | 34.5x | 15.2x | 9.9x–24.7x | 85 ↑rich |
| FCF Yield | 2.9% | -7.9% | -35.6%–1.4% | 80 ↑strong |
| Net Margin | 1.5% | -21.2% | -325.3%–7.2% | 66 ↑strong |
| Operating Margin | 2.3% | -34.5% | -552.0%–8.0% | 68 ↑strong |
| ROE | 10.8% | -36.8% | -92.5%–4.5% | 81 ↑strong |
